Title: Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.
Journal: Clinical drug investigation20110101
Title: Enantioselective analysis of oxybutynin and N-desethyloxybutynin with application to an in vitro biotransformation study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20081101
Title: The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))20071101
Title: Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
Journal: Life sciences20070606
Title: Pharmacokinetics/pharmacodynamics analysis of the relationship between the in vivo micturition pressure and receptor occupancy of (R)-oxybutynin and its metabolite in rats.
Journal: Biological & pharmaceutical bulletin20070501
Title: Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin.
Journal: Journal of clinical pharmacology20070301
Title: Stereoselective pharmacokinetics of oxybutynin and N-desethyloxybutynin in vitro and in vivo.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20070101
Title: Transdermal oxybutynin in the treatment of overactive bladder.
Journal: Clinical interventions in aging20060601
Title: Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion.
Journal: The Journal of pharmacology and experimental therapeutics20060301
Title: Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Journal: British journal of pharmacology20050501
Title: In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
Journal: Life sciences20050408
Title: [Effect of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl) glycolate, metabolite of oxybutynin, on intra-artery administered acetylcholine-induced urinary bladder contraction in anesthetized dogs].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20040501
Title: Effects of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate hydrochloride, a metabolite of oxybutynin, on bladder specimens and rhythmic bladder contraction in rats in comparison with oxybutynin.
Journal: Journal of pharmacological sciences20040201
Title: Oxybutynin extended-release: a review of its use in the management of overactive bladder.
Journal: Drugs20040101
Title: Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects.
Journal: Mayo Clinic proceedings20030601
Title: Sensitive determination of oxybutynin and desethyloxybutynin in dog plasma by LC-ESI/MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis20030226
Title: Transdermal oxybutynin: for overactive bladder.
Journal: Drugs & aging20030101
Title: Transdermal oxybutynin. A viewpoint by Michael Chancellor.
Journal: Drugs & aging20030101
Title: Transdermal oxybutynin. A viewpoint by Adrian Wagg.
Journal: Drugs & aging20030101
Title: Binding study of desethyloxybutynin using high-performance frontal analysis method.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20020225
Title: Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
Journal: Scandinavian journal of urology and nephrology20020201
Title: Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin.
Journal: The Journal of urology20011201
Title: Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers.
Journal: Pharmaceutical research20010701
